Literature DB >> 525981

Relationship between serum and saliva chloramphenicol concentrations.

J R Koup, A H Lau, B Brodsky, R L Slaughter.   

Abstract

The relationship between serum and saliva chloramphenicol (CAP) concentrations was evaluated in 27 paired specimens collected from 20 hospitalized patients during therapy with the drug. A significant (R = 0.80, P < 0.001) but variable relationship was found to exist. Serum protein binding of CAP was also evaluated (43.7 +/- 5.7% bound; N = 24). Differences in CAP binding did not apparently account for a significant portion of the variability in the observed saliva/serum CAP concentration ratios. The degree of variation observed indicated that saliva CAP concentrations could not be relied upon for the prediction of serum CAP concentrations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525981      PMCID: PMC352733          DOI: 10.1128/AAC.15.5.658

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  FATAL APLASTIC ANEMIA. AN EPIDEMIOLOGICAL STUDY OF ITS RELATIONSHIP TO THE DRUG CHLORAMPHENICOL.

Authors:  K M SMICK; P K CONDIT; R L PROCTOR; V SUTCHER
Journal:  J Chronic Dis       Date:  1964-10

2.  A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL.

Authors:  J L SCOTT; S M FINEGOLD; G A BELKIN; J S LAWRENCE
Journal:  N Engl J Med       Date:  1965-06-03       Impact factor: 91.245

3.  Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol.

Authors:  J M SUTHERLAND
Journal:  AMA J Dis Child       Date:  1959-06

4.  An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol.

Authors:  H LISCHNER; S J SELIGMAN; A KRAMMER; A H PARMELEE
Journal:  J Pediatr       Date:  1961-07       Impact factor: 4.406

5.  Fatal circulatory collapse in premature infants receiving chloramphenicol.

Authors:  L E BURNS; J E HODGMAN; A B CASS
Journal:  N Engl J Med       Date:  1959-12-24       Impact factor: 91.245

6.  Studies on excretion of antibiotics in human saliva. II. Chloramphenicol.

Authors:  I B BENDER; R S PRESSMAN; S G TASHMAN
Journal:  J Dent Res       Date:  1953-04       Impact factor: 6.116

7.  The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.

Authors:  J Grafnetterová; Z Vodrázka; D Jandová; O Schück; R Tomásek; J Lachmanová
Journal:  Clin Nephrol       Date:  1976-10       Impact factor: 0.975

Review 8.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

9.  Use of saliva in therapeutic drug monitoring.

Authors:  M G Horning; L Brown; J Nowlin; K Lertratanangkoon; P Kellaway; T E Zion
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

10.  Chloramphenicol-associated encephalopathy.

Authors:  P H Levine; W Regelson; J F Holland
Journal:  Clin Pharmacol Ther       Date:  1970 Mar-Apr       Impact factor: 6.875

View more
  2 in total

Review 1.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

2.  Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.

Authors:  J T Burke; W A Wargin; R J Sherertz; K L Sanders; M R Blum; F A Sarubbi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.